•  

Media Coverage

Miroculus acquires Kapplex to advance diagnostics for complex diseases

Canadian innovation will give patients affordable, non-invasive, accurate test for cancer or infectious diseases; R&D team to remain in Toronto discovery district TORONTO and SAN FRANCISCO (May 3, 2016) — Miroculus, a San Francisco-based biotechnology company specializing in microRNA-based diagnostics, today announced an agreement to acquire Toronto-based Kapplex Inc. The Canadian company’s proprietary Digital Microfluidic (DMF) platform is built upon the research of Dr. Aaron Wheeler, a world-leader in microfluidics research at the University of Toronto. This announcement was covered in GenomeWeb and PeHub. When ... Read more

BioTuesdays features Xagenic and company’s molecular diagnostic beta trials

"Closely-held Xagenic plans to conduct beta studies this year, in advance of a major chlamydia and gonorrhea clinical trial, with its rapid X1 molecular diagnostic testing system in preparation for market launches in Europe and the U.S.," Leonard Zahr wrote in a feature article on Xagenic's product development progress for BioTuesdays on April 19, 2016. Xagenic was founded by University of Toronto Professor Shana Kelley in partnership with MaRS Innovation and U of T's Innovations & Partnerships Office in 2010. The company ... Read more

MI’s Joel Liederman on CanadaAM to talk product development

Joel Liederman, vice-president of Physical Sciences, appeared on CanadaAM April 5, 2016 to talk about how to make a product. The interview is part of CanadaAM's "What's Next" segment on technology and entrepreneurship. He and host Beverly Thomson discussed the process for moving from a napkin to a prototype to a market-ready product, including market testing, prototyping, soliciting more customer feedback, and eventually product launch. "Marketing a product is a lot easier now than it used to be," said Liederman. "In the ... Read more

BlueDot profiled in Toronto Star for anticipating Zika virus spread

BlueDot, a Canadian company that helps decision-makers prepare for and response to infectious disease outbreaks, was profiled in the Toronto Star for their work in tracking the Zika virus. The company, founded by Dr. Kamran Khan, was spun-off from St. Michael's Hospital in partnership with MaRS Innovation. The company raised a Series A with Horzions Ventures in 2015. Here's an excerpt from Kate Allen's article: Wayne Gretzky may be an unlikely inspiration for an infectious disease researcher. Yet here Dr. Kamran Khan is, on ... Read more

MLA48 Angel Investment Fund Completes Third Investment in UTEST Company

MLA48 leads ConferenceCloud pre-seed round in cooperation with UTEST TORONTO, CANADA (January 11, 2016) — MLA48, Canada’s first angel investment fund committed to providing a 48-hour turnaround on investment decisions, has announced its third investment in ConferenceCloud, an innovative digital platform that provides a virtual solution for the next generation of hybrid conference events. TechVibes and BetaKit covered this announcement. The University of Toronto also published a web story on Olivia and John-Alan Simmons and their start-up journey. Founded in 2014 by siblings Olivia ... Read more

UTEST grad eQOL receives $350,000 for remote patient monitoring program

UTEST graduate eQOL has received $350,000 from the Ontario Government to support patients managing their kidney dialysis at home. eQOL's solutions use mobile tablets technology to support patients in managing independent care at home. The funding, part of an Ontario Centres of Excellence program to support technology used to remotely monitor and care for Ontario patients, was announced December 1, 2015 and covered in Canadian Healthcare Technology. eQOL has partnered with London Health Sciences Centre, Ontario Telemedicine Network and the Kidney Foundation of Canada ... Read more

University of Toronto sperm selection technology featured in the Toronto Star

"In a project spearheaded by PhD candidate Reza Nosrati, U of T researchers are trying to learn more about the way sperm cells move — something that could benefit those using in vitro fertilization (IVF)," writes Daniel Otis in "Sperm show U of T researchers a new trick: slithering" published in the Toronto Star on November 13, 2015. MaRS Innovation is working with Professor David Sinton, Nosrati and the university's Innovations and Partnerships Office to commercialize the technology for the human sperm ... Read more

Flybits named to Deloitte’s Technology Fast 50 Companies to Watch

Flybits, a Ryerson University start-up company created in partnership with MaRS Innovation, has been named to Deloitte's Technology Fast 50 Companies to Watch list. According to TechVibes, "Companies were selected for their technological innovation, entrepreneurship, leadership and growth. Now in its 18th year, Technology Fast 50 celebrated companies with an average four-year growth rate of 1,293%." You can read TechVibes' coverage of the Deloitte announcement here. The full list, of which 62% are software companies, is posted on Deloitte's website. (more…) Read more

UTEST cited among Toronto’s top 10 tech accelerators

UTEST, the tech accelerator co-directed by MaRS Innovation and the University of Toronto, was named to BlogTO's Top 10 list of technology accelerators on November 8, 2015. The list was published just weeks before the announcement of the fourth UTEST cohort, and included recognition of TrendMD and Whirlscape as notable startups among the graduated UTEST companies. Here's the excerpt: UTEST, a collaboration between U of T and MaRs Innovation, is in its fourth year of operation with 15 teams. The program is one year ... Read more

Encycle Therapeutics raises $2.85 million to advance macrocycle platform and pipeline

TORONTO, ON (September 30, 2015) — Encycle Therapeutics, Inc., a University of Toronto spin-off company created in partnership with MaRS Innovation, announced today that it has completed a $2.85 million (CAD) financing led by Takeda Pharmaceutical Company Ltd. through its venture capital arm, Takeda Ventures, Inc., with Accel-Rx Health Sciences Accelerator, BDC Capital and MaRS Investment Accelerator Fund. This news was covered in PEHub, BetaKit and TechVibes. The funding will support ongoing development of Encycle’s unique nacellin platform chemistry and advance the company’s ... Read more
Page 3 of 2012345...1020...Last »